Scientific research
Nathalie Maria Delzenne from Université Catholique de Louvain (Belgium) explains how gut microbiota and systemic inflammation impact cravings and depressive symptoms in affected individuals.
Including microbial load in microbiota studies can help researchers better understand how gut bacteria influence diseases, leading to more accurate diagnoses and effective treatments.
The findings suggest that gut microbes and LPC are potential therapeutic targets for Alzheimer's disease.
Researchers have identified a new class of virus-like agents known as "obelisks" in oral and stool samples from hundred of people.
The study identified a core microbiota signature that may serve as a health indicator and a therapeutic target.
Standardizing microbiome analysis improves the quality and reliability of data, helping researchers to explore the gut microbiota’s impact on athletes and its relationship with health and performance.
The interview with Antonia Bruno, from Bicocca University of Milan (Italy), highlights research focused on using microbial signatures to enhance food traceability, ensuring both safety and quality.
The interview with Björn O. Schröder from Umeå University explores groundbreaking research on the gut mucus layer, which shields intestinal tissues from bacterial invasion and inflammation.
The findings improve our understanding of the genetic complexity of the human gut microbiota and its implications for health.
Benoit Chassaing from institute Pasteur (France), delves into the ways various environmental factors, particularly dietary additives, affect the gut microbiome.
